Aktienkurs
114.64
Täglich Wechseln
-0.33 -0.29%
Monatlich
-2.80%
Jährlich
-27.19%
Q2 Prognose
114.37




Vermögenswerte Veränderung Datum
AbbVie USD 133.96B 62M 2025-12
Align Technology USD 6.31B 80.48M 2026-03
Bayer EUR 104.54B 331M 2025-12
Bristol-Myers Squibb USD 86.48B 3.56B 2026-03
Charles River Laboratories USD 7.14B 378.39M 2025-12
Coherus Biosciences USD 258.34M 258.18M 2025-12
Dentsply International USD 5.43B 224M 2025-12
Eli Lilly USD 116.58B 4.1B 2026-03
Henry Schein USD 11.22B 118M 2025-12
Idexx Laboratories USD 3.35B 35.95M 2025-12
Illumina USD 6.56B 85M 2026-03
IQVIA Holdings USD 29.94B 1.22B 2025-12
J&J USD 200.89B 1.68B 2026-03
Laboratory Of America USD 19.09B 694.4M 2026-03
Merck USD 136.87B 7.32B 2025-12
Neogen USD 3.36B 953K 2025-12
Pacira USD 1.21B 56.38M 2026-03
Perrigo USD 8.54B 1.55B 2025-12
Pfizer USD 208.73B 2.64B 2025-09
Phibro Animal Health USD 1.41B 20.03M 2025-12
Quest Diagnostics USD 16.67B 448M 2026-03
Sanofi EUR 128.02B 1.22B 2026-03
Sanofi EUR 126.81B 25.48B 2025-12
Zoetis USD 15.47B 308M 2025-12